U3 Pharma raises EUR 13.3M

Cancer company U3 Pharma (Martinsried, Germany) raised EUR 13.3 million ($14.7 million) in a series B round co-led by Atlas Venture and LCF Rothschild. Other investors included BioMedical Sciences Inv...